Using anti-HER2 CAR-T cells in combination with a PD-1 blocking antibody in a mouse xenograft breast cancer model, they were able to show that the CAR-T cells up-regulate PD-1 after binding to the tumor cells. Here, PDCD1 is linked to breast carcinoma.